Diagnamed Holdings Corp.
DMED
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 252.71% | 191.50% | 163.41% | 41.22% | -45.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 126.11% | 114.09% | 104.58% | 31.59% | -33.72% |
| Operating Income | -126.11% | -114.09% | -104.58% | -31.59% | 33.72% |
| Income Before Tax | -59.80% | -97.81% | -174.20% | -80.26% | -29.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.80% | -97.81% | -174.20% | -80.26% | -29.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.80% | -97.81% | -174.20% | -80.26% | -29.77% |
| EBIT | -126.11% | -114.09% | -104.58% | -31.59% | 33.72% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -21.43% | -56.45% | -126.09% | -62.50% | -29.63% |
| Normalized Basic EPS | -39.02% | -56.10% | -65.85% | -21.28% | 8.89% |
| EPS Diluted | -27.14% | -62.90% | -134.78% | -62.50% | -29.63% |
| Normalized Diluted EPS | -39.02% | -56.10% | -65.85% | -21.28% | 8.89% |
| Average Basic Shares Outstanding | 34.84% | 26.08% | 15.55% | 6.97% | 1.18% |
| Average Diluted Shares Outstanding | 34.84% | 26.08% | 15.55% | 6.97% | 1.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |